AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2009
Mar 12, 2009
34519_dirs_2009-03-12_6e70c925-a24a-49e8-9132-071e0a05b394.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-03-10
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-03-10 | Common stock, par value $0.10 per share | P | 200 | $2.00 | Acquired | 437327 | Direct |
| 2009-03-10 | Common stock, par value $0.10 per share | P | 1000 | $1.9981 | Acquired | 438327 | Direct |
| 2009-03-11 | Common stock, par value $0.10 per share | P | 99 | $1.76 | Acquired | 438426 | Direct |
| 2009-03-12 | Common stock, par value $0.10 per share | P | 876 | $1.7499 | Acquired | 439302 | Direct |
Footnotes
F1: These shares were acquired by Arterio, Inc., a company solely owned by Mr. Rothschild.
F2: This figure includes 185,073 shares of common stock held by Arterio, Inc., a corporation owned solely by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23